Emergent leads Mpox-linked stock gains as investors await approval
(Bloomberg) — Emergent BioSolutions Inc. led a rise this week in shares of companies working on vaccines and antiviral products as investors await a decision from U.S. regulators on whether the company’s smallpox vaccine can be used against the fast-spreading…
Why Emergent BioSolutions Stock Is Soaring Today
Shares of Emergent biosolutions (NYSE: EBS) were up 19.5% as of 11:09 a.m. ET on Friday, after rising as much as 34.1% earlier in the day. The big jump came after the European Centre for Disease Prevention and Control raised…
